Department of Nephrology, Jining No. 1 People's Hospital, Jining 272011, China.
Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, FL 32610, USA.
Mediators Inflamm. 2018 Dec 23;2018:4316584. doi: 10.1155/2018/4316584. eCollection 2018.
Myeloid-derived suppressor cells (MDSCs) are identified as a heterogeneous population of cells with the function to suppress innate as well as adaptive immune responses. The initial studies of MDSCs were primarily focused on the field of animal tumor models or cancer patients. In cancer, MDSCs play the deleterious role to inhibit tumor immunity and to promote tumor development. Over the past few years, an increasing number of studies have investigated the role of MDSCs in autoimmune diseases. The beneficial effects of MDSCs in autoimmunity have been reported by some studies, and thus, immunosuppressive MDSCs may be a novel therapeutic target in autoimmune diseases. There are some controversial findings as well. Many questions such as the activation, differentiation, and suppressive functions of MDSCs and their roles in autoimmune diseases remain unclear. In this review, we have discussed the current understanding of MDSCs in autoimmune diseases.
髓系来源的抑制细胞(MDSCs)被鉴定为具有抑制先天和适应性免疫反应功能的异质性细胞群体。MDSCs 的最初研究主要集中在动物肿瘤模型或癌症患者领域。在癌症中,MDSCs 发挥有害作用,抑制肿瘤免疫并促进肿瘤发展。在过去的几年中,越来越多的研究调查了 MDSCs 在自身免疫性疾病中的作用。一些研究报道了 MDSCs 在自身免疫中的有益作用,因此,免疫抑制性 MDSCs 可能是自身免疫性疾病的一种新的治疗靶点。也有一些有争议的发现。许多问题,如 MDSCs 的激活、分化和抑制功能及其在自身免疫性疾病中的作用仍不清楚。在这篇综述中,我们讨论了目前对自身免疫性疾病中 MDSCs 的认识。